NCT06971601

Brief Summary

The ETICHOFFA study is a clinical research project aiming to improve the diagnosis of Infrapatellar fat pad impingement syndrome, a common source of anterior knee pain. Although MRI remains the gold standard for diagnosis, clinical testing strategies lack validation. This observational study has two main objectives: to assess the diagnostic accuracy of a cluster of standardized clinical provocation tests for IFP impingement compared to MRI findings, and to identify clinical and subjective characteristics associated with IFP involvement confirmed by imaging. This observational study will recruit 50 patients aged 18 to 70 years with anterior knee pain rated at least 3 out of 10 in intensity. Participants will complete a secure online questionnaire documenting symptoms, pain distribution, aggravating and relieving factors, and pain intensity at rest, during activity, and daily life. They will also complete three validated scales: the Anterior Knee Pain Scale (AKPS), the Knee injury and Osteoarthritis Outcome Score (KOOS), and the Tampa Scale for Kinesiophobia (TSK). A standardized clinical examination will be performed, including subpatellar skin temperature measurement, knee swelling assessment, passive range of motion testing, and a series of provocation tests targeting Hoffa's fat pad. Tests will be randomized to reduce bias and considered positive if they reproduce the patient's typical pain with an intensity of at least 2/10. Each participant must also undergo a standardized MRI of the knee within two weeks of the clinical assessment, interpreted blindly by an independent musculoskeletal radiologist. All data will be anonymized, stored securely, and analyzed using SPSS software. Diagnostic accuracy of clinical tests will be evaluated through sensitivity, specificity, predictive values, and likelihood ratios. Functional outcomes related to taping will also be analyzed. The study has received ethical approval and adheres to GDPR standards for data protection. Participation is voluntary, with the right to withdraw at any time. The ETICHOFFA study is expected to enhance clinical diagnostic pathways for anterior knee pain associated with Infrapatellar fat pad involvement.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jun 2025Jun 2026

First Submitted

Initial submission to the registry

April 28, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 14, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

June 17, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

February 20, 2026

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

April 28, 2025

Last Update Submit

February 18, 2026

Conditions

Keywords

Hoffa's fat padInfrapatellar fat padDiagnosisMRI

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint of this study is the diagnostic value of the five clinical tests targeting the infrapatellar fat pad, considered collectively as a test cluster.

    The overall performance of the test cluster will be analyzed using contingency matrices comparing the combined clinical test results with MRI findings. Various combination strategies will be tested (e.g., ≥2 positive tests out of 5), and the following diagnostic validity indices will be calculated for each threshold: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likelihood ratios (LR⁺, LR-). ROC curves will be generated, and the area under the curve (AUC) will be used as a synthetic indicator of the cluster's discriminative capacity, with an AUC ≥ 0.80 considered clinically meaningful.

    At baseline (post-imaging and clinical assessment)

Secondary Outcomes (13)

  • Diagnostic performance of individual clinical tests

    At baseline (post clinical assessment)

  • Post-test probability of Infrapatellar fat pad impingement (Fagan nomogram analysis)

    At baseline (post-imaging and clinical assessment)

  • Infrapatellar skin temperature at rest (lying position)

    At baseline (during initial clinical assessment)

  • Presence of intra-articular swelling (Stroke Test)

    At baseline (during initial clinical assessment)

  • Passive range of motion of the knee (flexion and extension)

    At baseline (during initial clinical assessment)

  • +8 more secondary outcomes

Interventions

Provocative testDIAGNOSTIC_TEST

The clinical evaluation specific to Infrapatellar fat pad is based on a series of five standardized clinical tests, extensively described in the specialized literature: provoked palpation of the fat pad, provoked passive extension, Hoffa's test, gliding test, and provoked passive flexion. These tests are performed in a randomized order to limit sequence bias. A test is considered positive if it reproduces the patient's typical anterior knee pain with an intensity greater than 2/10 on the numerical pain scale. Although widely used, these tests have not yet undergone rigorous methodological validation, which this study specifically aims to address.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 to 70 years experiencing anterior knee pain (AKP) rated ≥3/10 for at least 4 weeks will be eligible. Patients will be recruited from the department of orthopedic and trauma at Hôpital Paris-Est Val de Marne (Saint-Maurice), including both postoperative cases (e.g., post-arthroscopy) and non-surgical patients referred for expert consultation regarding persistent or unexplained anterior knee pain.

You may qualify if:

  • Age between 18 and 70 years
  • Presence of anterior knee pain with an intensity of ≥3/10 on the Numerical Rating Scale (NRS), on most days over the past month
  • MRI of the knee performed within a maximum of 15 days before or after the clinical examination.

You may not qualify if:

  • History of corticosteroid injection treatment within the previous 12 months;
  • Known allergy or skin intolerance to medical adhesives or rigid tape;
  • History of hip or lumbar spine surgery;
  • History of neurological disorders or a diagnosis of fibromyalgia;
  • Contraindication to MRI (e.g., metallic foreign body, incompatible implantable device)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpitaux Paris Est Val-de-Marne - Service de rééducation orthopédique et traumatologie

Saint-Maurice, 94410, France

RECRUITING

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2025

First Posted

May 14, 2025

Study Start

June 17, 2025

Primary Completion

October 28, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

February 20, 2026

Record last verified: 2025-05

Locations